Comerica Bank
BCYC

Comerica Bank’s Bicycle Therapeutics BCYC Stock Holding History

Comerica Bank’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-110,940
Closed -$2.25M – 3680
2024
Q2 		$2.25M Buy
110,940
+32,170
+41% +$727K 0.01% 1078
2024
Q1 		$1.96M Sell
78,770
-3,080
-4% -$65.4K 0.01% 1185
2023
Q4 		$1.48M Buy
81,850
+81,400
+18,089% +$1.35M 0.01% 1325
2023
Q3 		$9.04K Buy
+450
New +$10.3K ﹤0.01% 3228

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Comerica Bank's BCYC Position: Q3 2024 in Review

Comerica Bank sold out of Bicycle Therapeutics (BCYC) in Q3 2024, closing a stake of 110,940 shares — an estimated $2.25M sold.

Comerica Bank first reported a position in BCYC in Q3 2023 and held it in 4 quarters. The position peaked at $2.25M in Q2 2024. 105 funds tracked by Wall St. Rank hold BCYC as of Q3 2024.

  • Comerica Bank reported no remaining Bicycle Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 110,940 Bicycle Therapeutics shares in Q3 2024, an estimated $2.25M.
  • Comerica Bank first reported a position in Bicycle Therapeutics in Q3 2023 and held it in 4 quarters.
  • Comerica Bank's Bicycle Therapeutics position peaked at $2.25M in Q2 2024.
  • 105 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.